The reduced neuroprotective effects of Il10-KO and Tgfa-KO CD8+ TRLs nonetheless support the essential role of these 2 molecules in the beneficial effects of CD8+ TRLs in stroke brains. The gene discussed is CD8A; the disease is stroke disorder.